About
Pulmair develops an implantable artificial bronchus device that is implanted bronchoscopically to treat patients with COPD and emphysema by reducing lung volume while preserving healthy lung tissue.
Explore Pulmair's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.